Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Feb 6, 2017; 8(1): 81-89
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.81
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.81
Table 5 Comparison between baseline St. marks incontinence score and cleveland clinic incontinence score of both study groups
| Baseline | CCIS Median (IQR) | SMIS Median (IQR) |
| IRAT pathway | 8.0 (33.5-11.5) | 13.0 (5.5-13.0) |
| Standard care pathway | 9.5 (5.0-15.0) | 12.0 (7.0-16.0) |
| P value | 0.11 | 0.18 |
- Citation: Hussain ZI, Lim M, Stojkovic S. Role of clinical pathway in improving the quality of care for patients with faecal incontinence: A randomised trial. World J Gastrointest Pharmacol Ther 2017; 8(1): 81-89
- URL: https://www.wjgnet.com/2150-5349/full/v8/i1/81.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i1.81